Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Common Equity (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Common Equity for 4 consecutive years, with $10.4 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity rose 23.02% year-over-year to $10.4 billion, compared with a TTM value of $10.4 billion through Dec 2025, up 23.02%, and an annual FY2025 reading of $10.4 billion, up 23.02% over the prior year.
  • Common Equity was $10.4 billion for Q4 2025 at GE HealthCare Technologies, up from $10.0 billion in the prior quarter.
  • Across five years, Common Equity topped out at $17.1 billion in Q2 2022 and bottomed at $6.7 billion in Q1 2023.
  • Average Common Equity over 4 years is $10.0 billion, with a median of $8.8 billion recorded in 2024.
  • The sharpest move saw Common Equity crashed 59.61% in 2023, then grew 24.51% in 2025.
  • Year by year, Common Equity stood at $9.4 billion in 2022, then decreased by 23.68% to $7.1 billion in 2023, then grew by 18.21% to $8.4 billion in 2024, then increased by 23.02% to $10.4 billion in 2025.
  • Business Quant data shows Common Equity for GEHC at $10.4 billion in Q4 2025, $10.0 billion in Q3 2025, and $9.7 billion in Q2 2025.